|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61P 3/00 | |||
| C07K 14/50 | |||
| C07K 19/00 |
| (11) | Patento numeris | 3377090 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16864846.7 |
| Europos patento paraiškos padavimo data | 2016-11-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/060944 |
| Data | 2016-11-08 |
| (87) | Numeris | WO 2017/083276 |
| Data | 2017-05-18 |
| (30) | Numeris | Data | Šalis |
| 201562252939 P | 2015-11-09 | US |
| (72) |
LING, Lei, US
LUO, Jian, US
TIAN, Hui, US
|
| (73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Boulevard, South San Francisco, CA 94080,
US
|
| (54) | METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS |
| METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS |